To further explore the role of c-FOS in RCC angiogenesis, we also applied siRNA strategy to KD c-FOS in ACHN/KD sublines and found that c-FOS KD could abolish the elevation of VEGFA after RASAL2 loss (Fig. 4b). This evidence concerns the gene VEGFA and renal cell carcinoma.